Immediate Impact

3 from Science/Nature 56 standout
Sub-graph 1 of 24

Citing Papers

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
2024 Standout
2 intermediate papers

Works of Robert Boucher being referenced

Nephrogenic Systemic Fibrosis and Class Labeling of Gadolinium-based Contrast Agents by the Food and Drug Administration
2012

Author Peers

Author Last Decade Papers Cites
Robert Boucher 50 41 11 61 54 6 246
William J. Pangonis 24 58 44 11 29 6 247
Matthew K. Edwards 26 7 8 13 121 16 208
Y. Agrawal 47 50 20 4 21 11 298
Hany Abd El-Raheem 10 41 19 86 58 14 242
P. Naik 3 17 4 30 46 11 219
Lois Weyer 22 63 23 9 17 8 252
K. Hoppstock 20 23 3 8 23 10 284
J.M. Begovich 76 68 2 8 42 14 193
Marta M. Andino 46 40 7 9 28 7 167
Ryan J. Gillis 11 49 23 4 77 8 250

All Works

Loading papers...

Rankless by CCL
2026